In another MC38 CRC cell study, high mobility group box 1 (HMGB1), a constituent part of NETs, interacted with toll-like receptor 9 (TLR9), followed by activation of MAP kinase signaling to perform tumorigenic functions [79]. The gene discussed is TLR9; the disease is colorectal carcinoma.